Ali Reza Keivanimehr | AI in healthcare | Best Researcher Award

Posted on by 21b4bddf87157652317827146367558f

Mr.Ali Reza Keivanimehr | AI in healthcare
| Best Researcher Award

Mr.  Ali RezaKeivanimehr ,  Amirkabir University of Technology (Tehran’s Polytechnic), Iran.

Ali Reza Keivanimehr is an exceptional early-career researcher with a solid academic foundation, a promising research trajectory in machine learning applications for healthcare, and strong technical expertise. His combination of research, teaching, and technical projects highlights a well-rounded profile. His contributions, especially in the use of TinyML for cardiovascular diagnosis, are commendable and align with global health priorities.

Publication Profile

Google scholar

Education :

Master of Science in Information Technology Engineering – Internet of Things (IoT) (2022 – 2025)Amirkabir University of Technology (Tehran Polytechnic), Tehran, IranRanked 403rd in QS World University Rankings 2024GPA: 3.53/4 (17.48/20) – 3rd highest in 2022 faculty entranceThesis: Applications of TinyML in Prediction and Diagnosis of Cardiovascular DiseasesSupervisor: Dr. Mohammad Akbari | Advisor: Dr. Abbas AhmadiBachelor of Science in Computer Engineering – Software Engineering (2018 – 2021)Imam Khomeini International University of Qazvin, Qazvin, IranProject: Designing a Software Interface for Industrial Machinery Maintenance

Experience :

Research Assistant (2022 – Present)
Data Science Lab (DSLab), Amirkabir University of Technology, Tehran, IranConducting research on TinyML and edge intelligence applications in cardiovascular disease prediction.Teaching Assistant — Machine Learning and Pattern Recognition (2024 – 2025)Amirkabir University of Technology, Tehran, IranAssisted in course instruction, project supervision, and student evaluations under Dr. Alireza Rezvanian.Teaching Assistant — Data Structure and Algorithms (2019 – 2020)
Imam Khomeini International University of Qazvin, Qazvin, IranSupported coursework delivery, assignments, and exam preparations under Morteza Mohammadi Zanjireh.

Research Focus :

Natural Language Processing (NLP)Graph Neural NetworksEdge IntelligenceExplainable Artificial Intelligence (XAI)Generative Adversarial Networks (GANs)Dr. Keivanimehr’s research centers on Tiny Machine Learning (TinyML) and edge intelligence, with a specific emphasis on their applications in cardiovascular disease monitoring. He explores the deployment of machine learning models on low-power, resource-limited devices to facilitate real-time analytics and pervasive monitoring for patients with cardiac anomalies.

Skills and Expertise:

As a research assistant, Dr. Keivanimehr has developed expertise in machine learning, classification, and supervised learning. His technical proficiency includes a focus on computational health and biomedical applications, particularly in the context of resource-constrained devices.Programming: PythonMachine Learning Frameworks: PyTorch, TensorFlowBig Data Tools: Apache SparkLanguages: TOEFL iBT (Score: 109 | Reading: 28 | Listening: 30 | Speaking: 26 | Writing: 25)

Awards:

 

48th Rank among 5000+ participants, National Entrance Exam for Master Studies in IT Engineering (2022)3rd Rank in IT Engineering Master’s cohort based on GPA (2022 – Present)Full Master’s Scholarship: Awarded for excellence in national entrance exams; covers tuition, dormitory, and partial food expenses (2022 – Present)Full Bachelor’s Scholarship: Granted for top performance in national entrance exams; included tuition, accommodation, and meal support (2018 – 2021)

 

Publication 

 

  • Keivanimehr, A., & Akbari, M. (2024). TinyML and Edge Intelligence Applications in Cardiovascular Disease: A Survey. Computers in Biology and Medicine. DOI: 10.1016/j.compbiomed.2025.109653

 

Conclusion

Ali Reza Keivanimehr is a suitable candidate for the Best Researcher Award. His strong academic record, impactful research, and consistent growth in machine learning and edge intelligence demonstrate his potential as a leading researcher in his field. With further international exposure and expanded publication efforts, he is poised to make significant contributions to both academia and industry.

 

Christian Poets| Medizintechnik | Excellence in Innovation

Posted on by 21b4bddf87157652317827146367558f

Prof .Christian Poets| Medizintechnik | Excellence in Innovation

Prof , Christian Poets,Universitätsklinikum Tübingen, Germany.

Professor Christian Poets is a renowned expert in neonatology and pediatric respiratory medicine at Universitätsklinikum Tübingen, Germany. He is recognized for his pioneering work in neonatal care, particularly focusing on respiratory disorders in newborns and preterm infants. Prof. Poets has contributed extensively to clinical research in infant sleep, breathing patterns, and Sudden Infant Death Syndrome (SIDS), improving both diagnostic and therapeutic approaches in neonatology. His research has had a significant impact on reducing infant mortality rates and enhancing care for preterm babies worldwide.

Summary:

Prof. Christian Poets is a highly accomplished researcher and clinician with a long track record of innovation in neonatology and pediatric care. His leadership in multicenter clinical trials and his contributions to both respiratory and craniofacial malformations research make him an outstanding candidate for the Research for Excellence in Innovation Award. His work spans clinical innovation, large-scale research, and interdisciplinary care, all of which contribute to advancing pediatric health care worldwide.

Professional Profiles:

Scopus

🎓 Education :

Christian F. Poets, MD, graduated from Hannover Medical School, Germany, in June 1986. He received his post-graduate medical training at the Department of Paediatric Pulmonology & Neonatology at Hannover Medical School, focusing on pediatric care. To further his expertise in sudden infant death syndrome (SIDS) research, he underwent specialized training at the Department of Paediatric Respiratory Physiology, Brompton Hospital & National Heart & Lung Institute, London, UK.

🏢 Experience:

In 1994, Dr. Poets was appointed Director of the Neonatal Intensive Care Unit and Paediatric Sleep Laboratory at Hannover Medical School. His leadership extended to the University of Tuebingen, Germany, where, since 2002, he has served as Chair and Medical Director of the Department of Neonatology. Additionally, in 2008, he became Chairman of the Interdisciplinary Centre for Cleft Palate and Craniofacial Malformations at Tuebingen University Hospital. Between 2020 and 2023, he also held the role of Acting Medical Director of Tuebingen University Children’s Hospital. He further enhanced his global profile by serving as a visiting professor at the Royal Children’s Hospital in Hobart, Australia, in 2019/2020 and again in early 2024.

🛠️Skills:

Dr. Poets’ expertise lies in neonatal care, pediatric sleep disorders, and the management of craniofacial malformations. His in-depth understanding of clinical trial coordination, combined with his experience in perinatal epidemiology, makes him a leading figure in neonatology research. He also has significant experience in leading interdisciplinary teams and is recognized for his commitment to ethical practices in clinical research.

Research Focus :

Dr. Poets’ research encompasses various pediatric and neonatal areas, focusing on breathing control, sleep apnea, intermittent hypoxia, and perinatal outcomes. His interest in congenital malformations has led to groundbreaking research on Robin sequence and craniofacial malformations. He is also deeply engaged in SIDS research, perinatal epidemiology, innate immunity, and ethical considerations in neonatal care. Furthermore, he actively participates in and leads multicenter clinical trials. He served as the Coordinator and Co-Principal Investigator (Co-PI) for NEuroSIS, a large EU-funded multicenter study on inhaled steroids for bronchopulmonary dysplasia (BPD) prevention. He is also on the steering committee for several major trials, including the COT and ETTNO trials, and serves on the Data Safety Monitoring Board (DSMB) of the DOXA and HiLo international trials.

🔬Awards:

Over his distinguished career, Dr. Poets has published over 440 research articles cited in PubMed and contributed to over 120 review articles. His influential work in neonatology, particularly in multicenter clinical trials, has earned him numerous accolades in the medical community. His leadership in establishing the Interdisciplinary Centre for Cleft Palate and Craniofacial Malformations and his research contributions to neonatal care highlight his commitment to advancing pediatric medicine on both a national and international scale.

Conclusion:

Given his extensive experience in innovative neonatal and pediatric research, Prof. Poets is a strong contender for the Research for Excellence in Innovation Award. His leadership in large clinical trials, commitment to interdisciplinary care, and international collaborations have created a lasting impact on pediatric health care. Addressing emerging technologies and ethical concerns could further strengthen his candidacy for future innovation awards.

Publications :

  • Delineating morbidity patterns in preterm infants at near-term age using a data-driven approach
    Ciora, O.-A., Seegmüller, T., Fischer, J.S., Ahmidi, N., Hilgendorff, A.
    BMC Pediatrics, 2024, 24(1), 249.

 

  • Detailed statistical analysis plan for ALBINO: effect of Allopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome — a blinded randomized placebo-controlled parallel group multicenter trial for superiority (phase III)
    Engel, C., Rüdiger, M., Benders, M.J.N.L., Stocker, M., Riedel, T.
    Trials, 2024, 25(1), 81.

 

  • Failure of an electric rocking device to improve neonatal sleep
    Poets, C.F., Roller, P., Neukamm, A.-C., Quante, M.
    Acta Paediatrica, International Journal of Paediatrics, 2024, 113(8), pp. 1791–1795.

 

  • Simulated model revealed significant continuous positive airway pressure fluctuations with facemasks
    Sterzik, H., Kumpf, M., Poets, C.F., Haase, B.
    Acta Paediatrica, International Journal of Paediatrics, 2024, 113(7), pp. 1531–1533.

 

  • Pulse oximetry signal loss during hypoxic episodes in preterm infants receiving automated oxygen control
    Langanky, L.O., Kreutzer, K.B., Poets, C.F., Franz, A.R., Schwarz, C.E.
    European Journal of Pediatrics, 2024, 183(7), pp. 2865–2869.

 

  • Randomised crossover study on pulse oximeter readings from different sensors in very preterm infants
    Maiwald, C.A., Schwarz, C.E., Böckmann, K., Poets, C.F., Franz, A.
    Archives of Disease in Childhood: Fetal and Neonatal Edition, 2024, 109(4), pp. 391–396.

 

  • Safe baby sleep in advertising | Sicherer Babyschlaf in der Werbung
    Kalus, E., Poets, C.F., Quante, M.
    Somnologie, 2024, 28(2), pp. 99–102.

 

  • Influence of malocclusion and orthodontic treatment in the masticatory efficiency of patients with craniofacial disorders
    Weismann, C., Schmidt, M., Effert, J., Koos, B., Aretxabaleta, M.
    Heliyon, 2024, 10(6), e28321.

 

  • Impact of flow-dependent imposed work of breathing for optimising neonatal CPAP with a T-piece device
    Sterzik, H., Arand, J., Molnar, K., Poets, C.F., Haase, B.
    Acta Paediatrica, International Journal of Paediatrics, 2024.

 

  • Facial growth dynamics dictate optimal facemask fitting during the first year of life
    Haase, B., Badinska, A.-M., Sowula, J., Poets, C.F., Wiechers, C.
    Acta Paediatrica, International Journal of Paediatrics, 2024.